Drug
Atomoxetine clinical trials
Also written LY139603.
- studies test it
- 143
- open now
- 13
- in phase 3
- 33
- first study started
- 1997
Keep track of what changes. Save the atomoxetine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- LY139603
- 26
Studies by the year they started
141 studies that test it; most in 2005 (26)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 12 |
| 2004 | 23 |
| 2005 | 26 |
| 2006 | 11 |
| 2007 | 9 |
| 2008 | 9 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 3
- Phase 1
- 19
- Phase 2
- 38
- Phase 3
- 33
- Phase 4
- 54
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 55 · Other 88
Eli Lilly and Company (50) · Massachusetts General Hospital (6) · Brigham and Women's Hospital (5) · Icahn School of Medicine at Mount Sinai (5) · Yale University (5) · University of Arizona (2) · Apnimed (2) · University of Calgary (2)
Often tested with
Tested in the same studies.
Methylphenidate (11) · Oxybutynin (5) · Acetazolamide (3) · Indomethacin (2) · Midodrine (2) · Modafinil (2) · Octreotide (2) · Rivastigmine (2)
Studies
Open first, then newest update. How each study uses atomoxetine is read from its arms, and is right about nine times in ten.
Testing it · 143
- Study of the Effects of Atomoxetine on MotivationNot yet recruitingPhase 4University of OxfordNCT07771595Written as Atomoxetine
- Atomoxetine in Melanocortin Obesity SyndromeRecruitingPhase 2Icahn School of Medicine at Mount SinaiNCT06899178Written as Atomoxetine
- Rescue Pharmacotherapy for OSARecruitingPhase 1/2Brigham and Women's HospitalNCT05293600Written as Atomoxetine and eszopiclone
- Atomoxetine and DAW2022 on OSA SeverityRecruitingPhase 1/2Brigham and Women's HospitalNCT05350215Written as Atomoxetine Oral Capsule [Strattera]
- Atomoxetine and Executive Function in PTSDRecruitingPhase 4VA Office of Research and DevelopmentNCT06573970Written as Atomoxetine
- Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal ApproachRecruitingPhase 3Radboud University Medical CenterNCT07316296Written as Atomoxetine
- Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)RecruitingNot applicableCentre Hospitalier St AnneNCT07239791Written as Atomoxetine
- Continuation Protocol for Obstructive Sleep Apnea (OSA)Enrolling by invitationPhase 3ApnimedNCT06566820Written as Aroxybutynin and Atomoxetine
- Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled StudyNot yet recruitingEarly Phase 1Tanta UniversityNCT06841666Written as Atomoxetine
- Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD RiskRecruitingPhase 4Icahn School of Medicine at Mount SinaiNCT03781765Written as Atomoxetine
- Study of Atomoxetine in the Prevention of Vasovagal SyncopeRecruitingPhase 3University of CalgaryNCT05159687Written as Atomoxetine Hydrochloride
- Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin TherapyRecruitingPhase 1/2Brigham and Women's HospitalNCT05550246Written as Atomoxetine
- Role of Coenzyme Q in ADHD in ChildrenRecruitingPhase 3Sherief Abd-ElsalamNCT04216186Written as Atomoxetine
- Treatment of Orthostatic IntoleranceActive, not recruitingPhase 1/2Satish R. RajNCT00262470Written as Atomoxetine
- A Novel Pharmacological Therapy for Obstructive Sleep ApneaCompletedPhase 2Brigham and Women's HospitalNCT03919955Written as Atomoxetine
- Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep ApneaCompletedPhase 4China Medical University HospitalNCT06295562Written as Atomoxetine 80mg combined with oxybutynin 5mg
- Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down SyndromeActive, not recruitingPhase 2University of ArizonaNCT05933603Written as Atomoxetine and Oxybutynin (ato-oxy)
- TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's DiseaseCompletedEarly Phase 1Hubert FernandezNCT02879136Written as Atomoxetine
- Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep ApneaCompletedPhase 1/2Brigham and Women's HospitalNCT05944965Written as Atomoxetine 80 mg plus Oxybutynin 5 mg
- Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With AutismCompletedPhase 3Massachusetts General HospitalNCT00498173Written as Atomoxetine
See all 143 studies that test atomoxetine →
Given in every arm · 2 — atomoxetine is usual care beside what is tested
As the comparator · 17 — what is tested is compared with atomoxetine
- An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's DiseaseRecruitingPhase 3University College, LondonNCT07724132Written as Atomoxetine
- Parallel Arm Trial of AD109 and AD504 In Patients With OSACompletedPhase 2ApnimedNCT05071612Written as Atomoxetine Hydrochloride
- A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)CompletedPhase 4ShireNCT04085172Written as Atomoxetine hydrochloride
- The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic StudyCompletedNot applicableNational Taiwan University HospitalNCT03936491Written as Atomoxetine
- Crossover Trial of AD036 in Obstructive Sleep ApneaCompletedPhase 2ApnimedNCT04445688Written as Atomoxetine
- Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)CompletedPhase 1/2ApnimedNCT05101122Written as Dosing 1: Atomoxetine
- Crossover Trial of AD109 in Obstructive Sleep ApneaCompletedPhase 2ApnimedNCT04580394Written as Atomoxetine
- The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity DisorderCompletedPhase 2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT03324581Written as Atomoxetine
- Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 3ShireNCT01244490Written as Atomoxetine Hydrochloride
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to MethylphenidateCompletedPhase 3ShireNCT01106430Written as Atomoxetine Hydrochloride
- Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHDCompletedPhase 4ShireNCT00506727Written as Atomoxetine hydrochloride
- Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.WithdrawnPhase 2PfizerNCT00562055Written as Atomoxetine
- EAA/Therapy for Treating Children With ADHDStatus unknownNot applicableSamsung Medical CenterNCT02482649Written as Atomoxetine
- A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT00880217Written as Atomoxetine 80 mg/d
- A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2AbbVie (prior sponsor, Abbott)NCT00528697Written as atomoxetine
- Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) ChildrenCompletedPhase 4Peking UniversityNCT01065259Written as Atomoxetine
- A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2AbbottNCT00429091Written as atomoxetine
Codes
What other systems call atomoxetine · ClinicalTrials.gg INT006579
- MeSH (NLM) D000069445Atomoxetine HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) ASW034S0B8ATOMOXETINEConfirmed FDA, NLM, Wikidata
- RxNorm 38400Confirmed FDA, Wikidata
- Wikidata Q417240atomoxetineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74141AtomoxetineOne source FDA
- DrugBank DB00289One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069445 | Atomoxetine Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | ASW034S0B8 | ATOMOXETINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 38400 | — | Confirmed FDA, Wikidata |
| Wikidata | Q417240 | atomoxetine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74141 | Atomoxetine | One source FDA |
| DrugBank | DB00289 | — | One source Wikidata |
Also registered as atomoxetine hydrochloride (UNII 57WVB6I2W0 · RxNorm 353103).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.